Science Explorer Interactive view Map
Research facility · Boston · United States

Thrombolysis in Myocardial Infarction Study Group

In research, Thrombolysis in Myocardial Infarction Study Group stands highest in Health Sciences (#3,614 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Cardiology and Cardiovascular Medicine — Cardiology and Cardiovascular Medicine is 26.7× its share of world research.

World rank, 2022–2025
#9,324
of 28,054 · #6,619 all time
Rank in United States
#1,243
of 4,192
Research works
426
▼ 4% vs 2013–17
Citations
30k
70.7 per fractional work
Top-10% rate
29.9%
record average 16.5%
Open access
37%
world 28%

What is Thrombolysis in Myocardial Infarction Study Group known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #3,614 of 11,982 30.6%61 #1730

Each strip is that field’s whole ranked pool, with the notch where Thrombolysis in Myocardial Infarction Study Group sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Thrombolysis in Myocardial Infarction Study Group specialise in?

Where its research is concentrated relative to its size: Cardiology and Cardiovascular Medicine takes 26.7× the share of its output that it takes of world research.

  1. Cardiology and Cardiovascular MedicineSubfield · 22.5 works27×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.52× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 2.01× its world share, 2 worksImmunology and Micro…Neuroscience: 0.98× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.89× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.08× its world share, 0 worksChemistryComputer Science: 0.08× its world share, 0 worksComputer ScienceEngineering: 0.34× its world share, 4 worksEngineeringEnvironmental Science: 0.24× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.02× its world share, 0 worksMaterials ScienceMathematics: 1.63× its world share, 2 worksMathematicsHealth Professions: 0.42× its world share, 1 worksHealth ProfessionsMedicine: 3.84× its world share, 59 worksMedicineNursing: 1.64× its world share, 1 worksNursingArts and Humanities: 0.14× its world share, 0 worksArts and HumanitiesDecision Sciences: 0.32× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.67× its world share, 1 worksEconomics, Econometr…Psychology: 0.23× its world share, 1 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.

Who are the top researchers at Thrombolysis in Myocardial Infarction Study Group?

Ranked on the composite score, Stephen D. Wiviott lead among researchers whose main affiliation is Thrombolysis in Myocardial Infarction Study Group.

  1. 1 Stephen D. Wiviott United States · #245,254 worldwide 389 citations · 16 works
All ranked researchers at Thrombolysis in Myocardial Infarction Study Group

Which keywords describe research at Thrombolysis in Myocardial Infarction Study Group?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Guidelines, Cardiovascular Disease, Heart Failure, Myocardial Infarction, Obesity, Atherosclerosis, Anticoagulant Therapy and Stroke Prevention.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Guidelines12▲ 31×6 topics
  2. Cardiovascular Disease12▲ 13×24 topics
  3. Heart Failure10▲ 30×11 topics
  4. Myocardial Infarction7▲ 39×7 topics
  5. Obesity7▲ 11×10 topics
  6. Epidemiology6▲ 2.0×24 topics
  7. Atherosclerosis6▲ 26×10 topics
  8. Inflammation5▲ 3.3×29 topics
  9. Anticoagulant Therapy5▲ 53×3 topics
  10. Diagnosis5▲ 6.8×11 topics
  11. Statins5▲ 86×2 topics
  12. Stroke Prevention5▲ 53×2 topics
  13. Atrial Fibrillation5▲ 63×2 topics
  14. Catheter Ablation5▲ 52×2 topics
  15. Risk Stratification5▲ 85×1 topic
  16. Thromboembolism5▲ 85×1 topic
  17. Risk Factors5▲ 5.4×10 topics
  18. Percutaneous Coronary Intervention4▲ 42×4 topics
  19. Thrombosis4▲ 20×7 topics
  20. Clinical Trials4▲ 8.0×5 topics
  21. Treatment4▲ 4.4×8 topics
  22. C-Reactive Protein4▲ 71×2 topics
  23. Cardiovascular Disease Prevention4▲ 56×2 topics
  24. Genetic Variants4▲ 28×3 topics
  25. Cholesterol-lowering4▲ 106×1 topic
  26. LDL Cholesterol4▲ 139×1 topic
  27. Metabolic Syndrome4▲ 5.8×10 topics
  28. Clinical Guidelines4▲ 16×4 topics
  29. Echocardiography4▲ 17×7 topics
  30. Glycemic Control3▲ 28×3 topics
  31. Insulin Therapy3▲ 36×3 topics
  32. Coronary Artery Disease3▲ 35×3 topics
  33. Type 2 Diabetes3▲ 18×3 topics
  34. Cardiovascular Risk3▲ 12×4 topics
  35. Diabetes3▲ 7.4×7 topics
  36. Acute Coronary Syndromes3▲ 97×1 topic
  37. Cardiac Imaging3▲ 29×3 topics
  38. Cholesterol3▲ 25×3 topics
  39. ST-Segment Elevation3▲ 97×1 topic
  40. Cardiovascular Events3▲ 27×4 topics

Which research topics does Thrombolysis in Myocardial Infarction Study Group publish most on?

By volume in 2022–2025: Atrial Fibrillation Management and Outcomes, Lipoproteins and Cardiovascular Health, Acute Myocardial Infarction Research and Cardiovascular Function and Risk Factors.

  1. 1 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 5 works
  2. 2 Lipoproteins and Cardiovascular Health Surgery 4 works
  3. 3 Acute Myocardial Infarction Research Cardiology and Cardiovascular Medicine 3 works
  4. 4 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 3 works
  5. 5 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
  6. 6 Mechanical Circulatory Support Devices Biomedical Engineering 2 works
  7. 7 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 2 works
  8. 8 Cardiac Imaging and Diagnostics Radiology, Nuclear Medicine and Imaging 2 works
  9. 9 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 2 works
  10. 10 Cardiac Arrest and Resuscitation Emergency Medicine 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.9%not open63.1%

World: 28% of research is openly available.

with international co-authors31.3%domestic only68.7%

World: 19% is written across borders.

How has Thrombolysis in Myocardial Infarction Study Group's research output changed?

Output in 2018–2022 was 4% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Boston

All research institutions in Boston

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.